不久前上海第二医科大 学人类基因治疗研究中心成 功地制备了胃癌“瘤苗”,并进 行了8例小样本临床试验,被 国家药品监督管理局批准进 入临床研究。此项课题领衔 者之一的陈诗书教授表示: “瘤苗”将用于120名手术后 复发、转移或不能手术的晚期 胃癌患者。 瘤苗,指的是由科研人页 Not long ago, Shanghai Second Medical University Human Gene Therapy Research Center succeeded in preparing gastric cancer “tumor vaccines” and carried out eight small-sample clinical trials, which were approved by the State Drug Administration for clinical research. Prof. Chen Shishu, one of the leaders of this topic, stated that “tumor vaccines” will be used in 120 patients with advanced gastric cancer who have relapsed, metastasized or are inoperable after surgery. Tumor vaccine, referring to the page of scientific research personnel